We found that increased levels of this receptor were present in high-grade urothelial bladder cancer lines and TNBC phenotype, which therefore were selected to be suitable in vitro models, and ATF-SAP was proven to recognize and kill uPAR-positive cells, proportionally to its expression, by inducing apoptotic cell death. The gene discussed is PLAU; the disease is bladder transitional cell carcinoma.